Cathepsin S Inhibition Suppresses Experimental Systemic Lupus Erythematosus-Associated Pulmonary Arterial Remodeling

Patients with systemic lupus erythematosus (SLE) associated with pulmonary arterial hypnertension (PAH) receive targeted therapy for PAH to decrease pulmonary arterial systolic pressure and significantly prolong their survival. Cysteine cathepsin proteases play critical roles in the progression of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Yen, Tzung-Hai, Ho, Wan-Jing, Yeh, Yung-Hsin, Lai, Ying-Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603876/
https://www.ncbi.nlm.nih.gov/pubmed/36293172
http://dx.doi.org/10.3390/ijms232012316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603876/
https://www.ncbi.nlm.nih.gov/pubmed/36293172
http://dx.doi.org/10.3390/ijms232012316

Ejemplares similares